Your browser doesn't support javascript.
loading
Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study).
Marwood, L; Taylor, R; Goldsmith, K; Romeo, R; Holland, R; Pickles, A; Hutchinson, J; Dietch, D; Cipriani, A; Nair, R; Attenburrow, M-J; Young, A H; Geddes, J; McAllister-Williams, R H; Cleare, A J.
Afiliação
  • Marwood L; Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. lindsey.marwood@kcl.ac.uk.
  • Taylor R; South London and Maudsley NHS Foundation Trust, London, UK. lindsey.marwood@kcl.ac.uk.
  • Goldsmith K; Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Romeo R; South London and Maudsley NHS Foundation Trust, London, UK.
  • Holland R; Biostatistics & Health Informatics Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Pickles A; Health Services and Population Research, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Hutchinson J; Biostatistics & Health Informatics Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Dietch D; Biostatistics & Health Informatics Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Cipriani A; Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Nair R; Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
  • Attenburrow MJ; Lonsdale Medical Centre, London, UK.
  • Young AH; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Geddes J; Oxford Health NHS Foundation Trust, Oxford, UK.
  • McAllister-Williams RH; Tees, Esk and Wear Valleys NHS Foundation Trust, Darlington, UK.
  • Cleare AJ; Department of Psychiatry, University of Oxford, Oxford, UK.
BMC Psychiatry ; 17(1): 231, 2017 06 26.
Article em En | MEDLINE | ID: mdl-28651526
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Transtorno Depressivo Maior / Transtorno Depressivo Resistente a Tratamento / Fumarato de Quetiapina / Lítio Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Health_economic_evaluation / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Transtorno Depressivo Maior / Transtorno Depressivo Resistente a Tratamento / Fumarato de Quetiapina / Lítio Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Health_economic_evaluation / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article